NeuroOne Joins Dartmouth Team on $1M NIH Neurotransmitter Grant
NeuroOne has joined a Dartmouth-led research team awarded a $1 million NIH grant to develop advanced neurotransmitter sensing technology.
NeuroOne, a medical technology company, has been named a partner in a Dartmouth-led research consortium that secured a $1 million grant from the National Institutes of Health to push forward the development of neurotransmitter sensing technology, according to an announcement from the company.
The collaboration positions NeuroOne alongside Dartmouth researchers in an effort to advance the ability to detect and measure neurotransmitters — chemical messengers that play a central role in brain function and are implicated in a range of neurological and psychiatric conditions. Improved sensing technology could have broad implications for both research and clinical applications.
Read more Thor Equities Lands $43.25M Loan for Savannah Industrial Portfolio →
NIH-backed grants of this scale are typically structured to fund early-stage and translational research, allowing academic institutions and private-sector partners to co-develop technologies that may eventually reach commercial or clinical use. NeuroOne's participation suggests the company is expanding its research footprint beyond its existing device portfolio.
The partnership underscores a broader trend of medtech firms embedding themselves in federally funded academic research, leveraging NIH dollars to accelerate innovation while sharing scientific resources with university teams. Dartmouth's role as the lead institution indicates the project will be anchored in the university's neuroscience research infrastructure.
Continue reading at GlobeNewswire - Mergers And Acquisitions.
